LUIS CAMACHO: Open Payments
NPI 1104418458 · LIBERAL, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$315 in 16 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $98 · 2025 $315
Food & beverage: $315
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $190 |
| Lilly USA, LLC | 2 | $34 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| IBSA Pharma Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
Products named: FARXIGA, BREZTRI, MOUNJARO, Tirosint, DEXCOM G7 GSS (161), QULIPTA, AIRSUPRA.
Industry payments across KS — which companies pay providers there.
